Bilateral Choroidal Effusions With Acute Myopic Shift After Daratumumab
Daratumumab is a CD38-directed monoclonal antibody increasingly used in haematological malignancies. Infusion-related reactions are well recognised, but ocular adverse events are uncommon and may be under-recognised. We report a man in his 30s with relapsed T-cell lymphoblastic lymphoma/leukaemia following allogeneic stem cell transplantation who developed acute bilateral blurred vision within 24 hours of his first daratumumab infusion. The infusion was complicated by a hypersensitivity reaction requiring treatment with antihistamines and corticosteroids. Ophthalmic assessment demonstrated unaided visual acuity of 6/9 in the right eye and 6/15 in the left eye, bilateral myopic refractive changes, normal intraocular pressures, and deep, quiet anterior chambers. Optical coherence tomography was unremarkable, whilst B-scan ultrasonography demonstrated small bilateral superior choroidal effusions. Following discussion with the treating haematology team, the patient was managed conservatively with ophthalmic monitoring whilst daratumumab was continued. At two weeks, his visual symptoms had resolved, unaided visual acuity had improved to approximately 6/4.5 bilaterally, and repeat ultrasonography confirmed complete resolution of the effusions. At approximately nine weeks, visual recovery was sustained, with near-plano autorefraction and no recurrent effusions. Daratumumab had subsequently been discontinued for unrelated haematological reasons. This case highlights ciliochoroidal effusion as a potential cause of acute myopic refractive change following daratumumab administration. Although the temporal association raises suspicion of drug-related ocular toxicity, causality cannot be established from a single case. Resolution during continued treatment illustrates a comparatively mild presentation but should not be interpreted as evidence that daratumumab can routinely be continued following ocular adverse events.
Authors
- Sheetal Shirke
- Angus van der Nagel (ORCID: https://orcid.org/0000-0001-5269-5957)
Institutions
- Townsville Hospital (AU)
Publication Details
- Journal
- Cureus
- Published
- 2026-11-18
- DOI
- https://doi.org/10.7759/cureus.119912
- Primary Topic
- Drug-Induced Ocular Toxicity
- Type
- article
- Field-Weighted Citation Impact
- 0.00